Breast Cancer Treatment Averts 'Collateral Damage' to Cells

Doctors meeting this week at a major conference in Chicago believe they are on track to create a drug that would specifically target cancer cells, while largely leaving healthy cells undamaged. Gwen Ifill and Dr. Michael Link of the American Society of Clinical Oncology discuss the findings.